申请人:SmithKline Beecham Corporation
公开号:US05663053A1
公开(公告)日:1997-09-02
Coenzyme A-independent transacylase is required for the release of free arachidonic acid, and the production of arachidonic acid metabolites and platelet activation factor. Blocking of this enzyme inhibits the production of these inflammatory mediators and will be of therapeutic utility in a broad range of allergic and inflammatory diseases and disorders. Compounds are described herein which inhibit the action of CoA-IT and are therefore useful in the treatment of disease states caused thereby.
需要Coenzyme A独立的转酰基酶来释放游离的花生四烯酸,并产生花生四烯酸代谢产物和血小板激活因子。阻断这种酶的作用可以抑制这些炎症介质的产生,在广泛的过敏和炎症性疾病和障碍的治疗中具有治疗用途。本文描述了抑制CoA-IT作用的化合物,因此在治疗由此引起的疾病状态中有用。